Immunohistochemical analyses showed that the levels of tumor angiogenic factors (HIF-1α and CD31), anti-apoptotic factor (survivin), and de novo protein synthesis regulators (p-4EBP1) were dramatically decreased upon fascaplysin treatment Figure 4B). The gene discussed is EIF4EBP1; the disease is neoplasm.